SEC Form SC 13G/A filed by Yumanity Therapeutics Inc. (Amendment)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
Kineta, Inc.
|
|
(Name of Issuer)
|
|
Common Stock, par value $0.001 per share
|
|
(Title of Class of Securities)
|
|
49461C 102
|
|
(CUSIP Number)
|
|
December 31, 2023
|
|
(Date of Event which Requires Filing of this Statement)
|
|
CUSIP No. 49461C 102
|
||||
|
1
|
NAMES OF REPORTING PERSONS
|
|||
|
Charles Magness
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|||
|
(a) ☐
(b) ☐ |
||||
|
3
|
SEC USE ONLY
|
|||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|||
|
U.S.A.
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY
EACH REPORTING PERSON WITH: |
5
|
SOLE VOTING POWER
|
||
|
613,254
|
||||
|
6
|
SHARED VOTING POWER
|
|||
|
7,159*
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|||
|
613,254
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|||
|
7,159*
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
620,413
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|||
| ☐ | ||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|||
|
6.1%**
|
||||
|
12
|
TYPE OF REPORTING PERSON
|
|||
|
IN
|
||||
|
Dated: February 12, 2024
|
CHARLES MAGNESS
|
| /s/ Charles Magness |
|